购物车
您的购物车当前为空
别名 抗FGFR1/CD331抗体
Anti-FGFR1/CD331 Antibody 是一种针对成纤维细胞生长因子受体 1 (FGFR1/CD331) 的人源化单克隆抗体。FGFR1 属于受体酪氨酸激酶 (RTK) 家族,在调节细胞增殖、存活、迁移及血管生成中发挥关键作用。该抗体通过特异性结合 FGFR1 的胞外结构域,竞争性阻断 FGF 配体的结合,进而抑制受体自磷酸化及下游信号通路(如 MAPK/ERK 和 PI3K/Akt)的激活。这一机制可有效抑制由 FGFR1 信号异常驱动的肿瘤生长及组织病理性增生,常用于实体瘤研究及相关癌症治疗药物的开发。
Anti-FGFR1/CD331 Antibody 是一种针对成纤维细胞生长因子受体 1 (FGFR1/CD331) 的人源化单克隆抗体。FGFR1 属于受体酪氨酸激酶 (RTK) 家族,在调节细胞增殖、存活、迁移及血管生成中发挥关键作用。该抗体通过特异性结合 FGFR1 的胞外结构域,竞争性阻断 FGF 配体的结合,进而抑制受体自磷酸化及下游信号通路(如 MAPK/ERK 和 PI3K/Akt)的激活。这一机制可有效抑制由 FGFR1 信号异常驱动的肿瘤生长及组织病理性增生,常用于实体瘤研究及相关癌症治疗药物的开发。

| 产品描述 | Anti-FGFR1/CD331 Antibody is a humanized monoclonal antibody targeting fibroblast growth factor receptor 1 (FGFR1/CD331). FGFR1 is a member of the receptor tyrosine kinase (RTK) family, playing a pivotal role in regulating cell proliferation, survival, migration, and angiogenesis. This antibody specifically binds to the extracellular domain of FGFR1, competitively blocking FGF ligand binding and subsequently inhibiting receptor autophosphorylation and the activation of downstream signaling pathways such as MAPK/ERK and PI3K/Akt. This mechanism effectively suppresses tumor growth and pathological hyperplasia driven by aberrant FGFR1 signaling, making it a valuable tool in research on solid tumors and the development of targeted cancer therapies. |
| 别名 | 抗FGFR1/CD331抗体 |
| 反应种属 | Human |
| 应用 | ELISA FACS Functional assay |
| 抗体种类 | Monoclonal |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 同型 | IgG1 |
| 偶联 | Unconjugated |
| Uniprot ID | |
| 靶点 | FGFR1/CD331 |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多